卡多纳, 安德烈斯·F.

Andrés Felipe Cardona is the head of research, science, and education of the Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC) in Bogotá, Colombia. He is also an associated professor at the Universidad El Bosque and Universidad de los Andes Faculties of Medicine. He obtained his medical degree at the Universidad del Rosario (Bogotá, Colombia) and then specialized in epidemiology at the same institution. After that, Doctor Cardona did postgraduate studies in internal medicine, clinical oncology, and clinical epidemiology. He also obtained a Ph.D. in tumor genomics, emphasizing translational research. During his carecer he has carried out formal studies in thoracic oncology and brain tumors at the Instituto Catalán de Oncología and obtained another master's degree in molecular oncology at the Centro Nacional de Investigaciones Oncológicas (CNIO). His current areas of interest include searching for biomarkers to predict the response to therapeutic interventions directed against lung cancer, melanoma, and brain tumors. He also shows a particular inclination towards carrying out phase I/II cancer clinical trials and developing systematic reviews and CPGs referring to tumor pathology in developing countries. During the last decade, he has been dynamically involved in creating the Colombian Cochrane Collaboration Group, the Latin-American On-going Clinical Trials Register (LATINREC), the Latin-American Neuro-Oncology Network (RedLANO) and the Latin-American Consortium for Lung Cancer Research (CLICaP). He also is a co-founder of the Foundation of Clinical and Applied Cancer Research (FICMAC). Doctor Cardona contributed to many local, regional and international medical journals and has authored over +200 articles published in peer-reviewed scientific journals (H-Index 44/Total research interest 4,819/Total citations 10.300). He has given more than +250 presentations at medical conferences around the world.